US biotech firm NiKang Therapeutics raises $200m in Series C round

US biotech firm NiKang Therapeutics raises $200m in Series C round

Photo: Pixabay

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter